| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 21, 2026 | Option exercise(M) | 80K | $4.73 | $378K | 347K |
| Aug 21, 2026 | Sell(S) | 5K | $207.23 | $1.1M | 342K |
| Aug 21, 2026 | Sell(S) | 25K | $208.37 | $5.2M | 317K |
| Aug 21, 2026 | Sell(S) | 36K | $209.26 | $7.5M | 281K |
| Aug 21, 2026 | Sell(S) | 4K | $210.25 | $802K | 278K |
| Aug 21, 2026 | Sell(S) | 7K | $211.33 | $1.4M | 271K |
| Aug 21, 2026 | Sell(S) | 4K | $212.08 | $768K | 267K |
| Aug 21, 2026 | Sell(S) | 190 | $207.25 | $39K | 64K |
| Aug 21, 2026 | Sell(S) | 951 | $208.36 | $198K | 63K |
| Aug 21, 2026 | Sell(S) | 1K | $209.28 | $283K | 62K |
| Aug 21, 2026 | Sell(S) | 136 | $210.40 | $29K | 62K |
| Aug 21, 2026 | Sell(S) | 245 | $211.47 | $52K | 62K |
| Aug 21, 2026 | Sell(S) | 127 | $212.06 | $27K | 61K |
| Aug 21, 2026 | Sell(S) | 177 | $207.25 | $37K | 64K |
| Aug 21, 2026 | Sell(S) | 937 | $208.36 | $195K | 63K |
| Aug 21, 2026 | Sell(S) | 1K | $209.27 | $294K | 62K |
| Aug 21, 2026 | Sell(S) | 126 | $210.40 | $27K | 62K |
| Aug 21, 2026 | Sell(S) | 229 | $211.46 | $48K | 62K |
| Aug 21, 2026 | Sell(S) | 126 | $212.06 | $27K | 61K |
| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 21, 2026 | Option exercise(M) | 80K | — | $0 | 344K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000387) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Revolution Medicines, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.